WO2024180569 - A SYNERGISTIC AQUEOUS NEBULIZATION SUSPENSION FOR MANAGEMENT OF INFECTIOUS RESPIRATORY DISORDERS AND PROCESS OF PREPARATION
National phase entry is expected:
Publication Number
WO/2024/180569
Publication Date
06.09.2024
International Application No.
PCT/IN2024/050213
International Filing Date
29.02.2024
Title **
[English]
A SYNERGISTIC AQUEOUS NEBULIZATION SUSPENSION FOR MANAGEMENT OF INFECTIOUS RESPIRATORY DISORDERS AND PROCESS OF PREPARATION
[French]
SUSPENSION DE NÉBULISATION AQUEUSE SYNERGIQUE POUR LA GESTION DE TROUBLES RESPIRATOIRES INFECTIEUX ET PROCESSUS DE PRÉPARATION
Applicants **
KANDURI, Ajaykumar Balraj
Flat No. 302, Satyam Pride, Near Navi Mumbai Police Headquarters,
Sector-20, Roadpali, Kalamboli
Navi Mumbai 410218, IN
Inventors
KANDURI, Ajaykumar Balraj
Flat No. 302, Satyam Pride, Near Navi Mumbai Police Headquarters,
Sector-20, Roadpali, Kalamboli
Navi Mumbai 410218, IN
Priority Data
202321013865
01.03.2023
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
IP India
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 996 | |
| EPO | Filing, Examination | 5015 | |
| Japan | Filing | 531 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 4435 |
Total: 11552 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present disclosure relates to non-antibiotic formulation towards elimination of infectious respiratory disorders. More specifically, the present disclosure is directed to a synergistic aqueous nebulization suspension comprising a combination of Sodium Chloride (NaCl), Magnesium Sulphate (MgSo4), Calcium bicarbonate [Ca(HCO3)2], Potassium Chloride (KCl), Iodine (I2) / Hypoiodous acid, Aluminium Nanoparticle (Gamma Al2O3) having Particle size 5-50 nm, Glyoxylic acid, Malonic acid, Succinic acid in a therapeutically effective amount that synergistically show activity against infectious diseases that affect the respiratory system including Tuberculosis and SARS-CoV-2, and to a process of preparation thereof.[French]
La présente divulgation concerne une formulation non antibiotique visant l'élimination de troubles respiratoires infectieux. Plus spécifiquement, la présente divulgation concerne : une suspension de nébulisation aqueuse synergique comprenant une combinaison de chlorure de sodium (NaCl), de sulfate de magnésium (MgSo4), de bicarbonate de calcium [Ca(HCO3)2], de chlorure de potassium (KCl), d'iode (I2)/acide hypoiodeux, de nanoparticules d'aluminium (Gamma Al2O3) ayant une taille de particule de 5 à 50 nm, d'acide glyoxylique, d'acide malonique, d'acide succinique en une quantité thérapeutiquement efficace qui présentent de manière synergique une activité contre des maladies infectieuses qui affectent le système respiratoire comme la tuberculose et le SARS-CoV-2 ; et un processus de préparation de celle-ci.